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During blood vessel formation, endothelial cells
(ECs) establish cell-cell junctions and rearrange to
form multicellular tubes. Here, we show that during
lumen formation, the actin nucleator and elongation
factor, formin-like 3 (fmnl3), localizes to EC junctions,
where filamentous actin (F-actin) cables assemble.
Fluorescent actin reporters and fluorescence recov-
ery after photobleaching experiments in zebrafish
embryos identified a pool of dynamic F-actin with
high turnover at EC junctions in vessels. Knockdown
of fmnl3 expression, chemical inhibition of formin
function, and expression of dominant-negative
fmnl3 revealed that formin activity maintains a stable
F-actin content at EC junctions by continual polymer-
ization of F-actin cables. Reduced actin polymeri-
zation leads to destabilized endothelial junctions
and consequently to failure in blood vessel lumeniza-
tion and lumen instability. Our findings highlight
the importance of formin activity in blood vessel
morphogenesis.
INTRODUCTION
The establishment and maintenance of functional blood vessels
is crucial during development. Vessel lumenization involves api-
cal membrane invagination and cellular rearrangements (Axnick
and Lammert, 2012; Herwig et al., 2011; Lenard et al., 2013).
Molecules that regulate vessel lumenization include vascular
endothelial (VE)-cadherin (Lampugnani et al., 2010; Montero-
Balaguer et al., 2009; Strilic et al., 2009; Wang et al., 2010),
CCM1 (Lampugnani et al., 2010), b1 integrin (Zovein et al.,
2010), VE-phosphotyrosine phosphatase (VE-PTP) (Hayashi
et al., 2013), podocalyxin (Strilic et al., 2009), Rasip1 (Xu et al.,
2011), Moesin 1 (Strilic et al., 2009; Wang et al., 2010), PP2ADevelopm(Martin et al., 2013) and Amotl2 (Hultin et al., 2014). A common
feature of these molecules is their ability to associate to or regu-
late the filamentous actin (F-actin) cytoskeleton. Thus, the actin
cytoskeleton is an effector of lumen formation. However, how the
actin cytoskeleton or which actin structure regulates vessel
lumenization in vivo is unknown.
Formin proteins regulate both the actin and microtubule
cytoskeleton and play important roles in cell division, cell
migration, adherens junction formation, and development
(Bartolini and Gundersen, 2010; DeWard et al., 2010). Fifteen
mammalian formin proteins have been identified and include
Diaphanous-related formin 1 to 3 (Dia 1–3) and formin-like
protein 1 to 3 (fmnl 1–3). Formins are characterized by the
presence of formin homology (FH) domains, FH1 and FH2,
and contain a GTPase-binding domain regulated by Rho
GTPases (Scho¨nichen and Geyer, 2010). Formins act as actin
nucleation and elongation factors to promote the assembly of
linear actin filaments. The FH1 domain binds to the actin
monomer-binding protein profilin, while the FH2 domains
form homodimers that associate to F-actin barbed ends to
initiate actin nucleation.
Fmnl3 is selectively expressed in endothelial cells (ECs) during
zebrafish embryonic development, where it influences interseg-
mental vessel (ISV) formation (Hetheridge et al., 2012; Santos-
Ledo et al., 2012). However, it is unclear how fmnl3 regulates
angiogenesis. In this study, we demonstrate that fmnl3 regulates
F-actin assembly at EC junctions to promote junction stability
and vessel integrity.RESULTS
Formin Activity Regulates Lumen Formation and
Maintenance
Similar to human FMNL3 in cultured cells (Harris et al., 2010), we
detected EGFP tagged zebrafish fmnl3 (fmnl3-EGFP) in endo-
thelial filopodia during zebrafish ISV development (Figures S1A
and S1B available online). Knockdown of fmnl3 expression using
antisense morpholino (Hetheridge et al., 2012) resulted in a smallental Cell 32, 123–132, January 12, 2015 ª2015 Elsevier Inc. 123
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but significant decrease in endothelial filopodia number (p =
0.0013; Figures S1E–S1G) and length (p < 0.0001; Figures
S1E, S1F, and S1H) during ISV formation. In contrast to a previ-
ous report (Hetheridge et al., 2012), the decrease in filopodia for-
mation did not perturb ISV development (Figures S1I–S1K).
However, fmnl3 knockdown prevented the formation of distinct
dorsal and ventral veins in the caudal vein plexus (Figures S1L
and S1M). The role of fmnl3 in the formation of this caudal vein
plexus is covered in a separate paper in this issue of Develop-
mental Cell (Wakayama et al., 2015).
Additionally, we discovered that formin inhibition perturbed
lumen formation in the ISVs. Examination of 2 dpf fmnl3 mor-
phants and embryos treated with SMIFH2, a broad-spectrum
formin inhibitor (Rizvi et al., 2009), from 31 hpf, revealed poorly
lumenized ISVs (Figures 1B and 1D) compared with control em-
bryos (Figures 1A and 1C). ECs expressing a truncated form of
fmnl3 lacking the catalytic C terminus FH1, FH2, and DAD do-
mains (fmnl3DC) showed reduced linear F-actin cables at the
cell cortex and a more relaxed morphology compared with con-
trol cells (Figure S1N). Quantification of ISVs with mosaic
fmnl3DC expression revealed a decrease in the number of fully
lumenized ISVs (p = 0.0002; Figures 1E–1G). Microangiography
in 54–57 hpf embryos identified a significant decrease in the
number of ISVs with continuous perfusion in fmnl3 morphants
(p < 0.0001; Figures 1H–1J). Similarly, the flow of erythrocytes
through ISVs was decreased in fmnl3 morphants (p < 0.0001;
Figure 1K) and was partially rescued by overexpression of
fmnl3 mRNA (p < 0.0019; Figure 1K).
We next asked whether fmnl3 also controls lumen mainte-
nance. In embryos treated with DMSO at 2 dpf, ISVs remained
lumenized and displayed distinct longitudinal junctional F-actin
cables (Figure 1L). In contrast, inhibition of formin activity using
SMIFH2 for 4 to 5 hr resulted in a loss of continuous lumen within
ISVs (Figure 1M). Injections of quantum dots into the blood flow
of embryos at 50 hpf and immediate treatment with DMSO or
SMIFH2 confirmed a loss of vessel functionality after formin inhi-
bition. In control embryos, ISVs, dorsal longitudinal anastomotic
vessels (DLAVs), the dorsal aorta (DA), and the posterior cardinal
vein (PCV) were continuously perfused (Figure 1N). However,
SMIFH2 treatment resulted in the trapping of quantum dots
within segments of the ISVs (Figure 1O), demonstrating the
disruption of previously formed lumen. Furthermore, SMIFH2Figure 1. Formin Activity Is Required for Vessel Lumen Formation and
(A–D) Tg(fli1ep:Lifeact-EGFP);Tg(kdr-l:ras-Cherry)s916 embryos were injecte
SMIFH2 from 31 to 46 hpf and examined at 50 hpf. The asterisk shows lu
represent 10mm.
(E–G) Mosaic expression of EGFP or fmnl3DC-EGFP in ISVs of Tg(kdr-l:ras-Cher
phenotyped for lumen defects (G). EGFP, n = 41 ISVs, n = 16 embryos; fmnl3DC
(H–J) Tg(kdr-l:ras-Cherry)s916 embryos were injected with quantum dots (Qdot) at 5
n = 28 embryos; fmnl3 MO, n = 186 ISVs, n = 36 embryos. Scale bars represent
(K) Quantification of blood flow through ISVs. Control MO, n = 79 embryos; Fmnl3
represent mean ± SD.
(L–O) Uninjected or Qdot-injected Tg(fli1ep:Lifeact-EGFP);Tg(kdr-l:ras-Cherry)s91
4–5 hr later. (L andM) Arrowheads show junctional F-actin cables. The arrow show
of Qdot-filled vessels, and the arrowhead shows vessel disconnection. Scale ba
(P–S)Mosaic endothelial EGFP or fmnl3DC-EGFP expression (serrated lines) was
for lumen defects. Arrows show unlumenized vessel. EGFP, n = 42 ISVs, n
represent 20 mm.
See also Figure S1.
Developmtreatment led to cell disconnections within the ISVs (Figure 1O).
To test the specific requirement of fmnl3 in lumen maintenance,
we induced the expression of dominant-negative fmnl3DC spe-
cifically in ECs at 2 dpf using the mifepristone-inducible LexPR
system (Emelyanov and Parinov, 2008). ISVs with mosaic
expression of fmnl3DC revealed a decrease in the number of fully
lumenized ISVs at 3 dpf compared with ISVs with mosaic EGFP
expression (p < 0.0001; Figures 1P–1S).
In summary, these experiments demonstrate that formin
activity regulates lumen formation and maintenance during
angiogenesis.
Fmnl3 Does Not Regulate Microtubule Filament
Assembly in ECs In Vivo
As fmnl3 was suggested to regulate microtubule alignment in
angiogenic sprouts (Hetheridge et al., 2012), we asked whether
potential microtubule defects contributed to lumen disruption.
Coexpression of fmnl3-EGFP and mCherry-Doublecortin
(DCX), a microtubule marker (Figure S2A), did not show colocal-
ization of fmnl3 tomicrotubule filaments (Figure 2A). In 48–50 hpf
Tg(fli1ep:EGFP-DCX) embryos injected with control morpholino
(Figure 2B) or treated with DMSO (Figure 2D), ECs displayed
long, thin microtubule filaments. In fmnl3 morphants (Figure 2C)
and embryos treated for 2 hr with SMIFH2 (Figure 2E), microtu-
bule filaments were still observed in ECs of unlumenized seg-
ments of ISVs. Interestingly, ISVs remained lumenized after
2 hr nocodazole treatment, although microtubule filaments
were depleted (Figure 2F). These findings suggest that the
microtubule cytoskeleton is not essential for lumen maintenance
in the short term and that formins do not regulate vessel lumen
integrity through the microtubule skeleton.
Formin Activity Maintains a Pool of Dynamic F-Actin at
Endothelial Junctions
As blood vessels mature, ECs rearrange to form a multicellular
tube. During this phase, fmnl3 translocates from the cytoplasm
to junctions, where F-actin cables assemble (Figures 2G, S1C,
and S1D). The colocalization of fmnl3 with junctional F-actin sug-
gests a role of fmnl3 in promoting F-actin cable assembly at EC
junctions. We next examined junctional F-actin in the DA and the
PCV inmore detail since junctions of ISVs disintegrate within 1 to
2 hr of SMIFH2 treatment (Figure 4G). Analysis of F-actin cablesMaintenance
d with control or fmnl3 morpholino or treated with DMSO or 5 mM
menized ISV, and arrowheads show junctional F-actin cables. Scale bars
ry)s916 embryos at 52 hpf. ISVs with EGFP or fmnl3DC-EGFP expression were
-EGFP, n = 52 ISVs, n = 27 embryos. Scale bars represent 10 mm.
4–57 hpf. The arrow shows discontinuous perfusion. Control MO, n = 134 ISVs,
50 mm.
MO, n = 87 embryos; Fmnl3 MO + 100pg fmnl3mRNA, n = 64 embryos. Data
6 embryos were treated with DMSO or 10 mMSMIFH2 at 49–50 hpf and imaged
s apical membrane, and the asterisk shows lumen. (O) Arrows show fragments
rs represent 20 mm.
induced in Tg(kdr-l:ras-Cherry)s916 embryos at 2 dpf and examined at 71–77 hpf
= 16 embryos; fmnl3DC-EGFP, n = 57 ISVs, n = 33 embryos. Scale bars
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revealed a decrease in straight cables and an increase in
serrated cables at the junctions of both the DA and PCV after
5 hr SMIFH2 treatment (Figures 2H–2J). Serrated junction pro-
files have been observed in vitro and in vivo at active junctions
after VE growth factor (VEGF) treatment and at remodeling junc-
tions (Bentley et al., 2014). Hence, the increase in serrated F-
actin cables after formin inhibition suggests decreased F-actin
stability at cell junctions.
As formins catalyze the nucleation of actin filaments, we
examined whether the decrease in F-actin stability is a conse-
quence of altered F-actin polymerization by measuring the
fluorescence recovery of EGFP-Actin at cell junctions after pho-
tobleaching (FRAP) in Tg(fli1ep:EGFP-Actin) embryos (Figures
S2B and S2C). FRAP experiments revealed that 47.9% and
57.4% of the F-actin population at junctions of the DA and
PCV, respectively, are mobile (Figure 4L). The mobile fraction
of EGFP-Actin at cell junctions of the DA and PCV of control em-
bryos recovered rapidly after photobleaching (half-life of 7.3 ±
2.8 s at DA and 7.1 ± 3.1 s at PCV; Figures 2K and 2M). This re-
covery can occur through the diffusion of monomeric EGFP-
Actin or through nucleation of EGFP-Actin at the junctions. As
diffusive recovery occurs within 50 ms (Fritzsche et al., 2013),
we assumed that monomeric EGFP-Actin distribution was ho-
mogeneous (Halavatyi et al., 2010) and that the recovery of the
mobile EGFP-Actin fraction was a result of F-actin polymeriza-
tion. Thus, our FRAP study revealed a mobile pool of dynamic
F-actin with high turnover at EC junctions.
The mobile fraction of junctional EGFP-Actin in both the DA
and PCV remained unaffected after formin inhibition (Figure 2L).
However, 5 hr SMIFH2 treatment resulted in a significant in-
crease of 3 s in half-life in the PCV compared with DMSO-treated
embryos (p = 0.0481) (Figure 2M). Thus, formin-mediated F-actin
polymerization contributes to the recovery of the mobile pool of
junctional EGFP-Actin to maintain a stable F-actin content and,
therefore, F-actin cable assembly, at EC junctions.
Junctional F-Actin Cables Assemble during Lumen
Formation
To better understand how fmnl3 regulates ISV lumenization, we
turned to live imaging of Tg(fli1ep:Lifeact-EGFP);Tg(kdr-l:ras-
Cherry)s916 embryos to visualize endothelial actin andmembrane
dynamics, respectively. In these embryos, the apical membrane
can be clearly distinguished by mCherryCAAX enrichment at the
apical membrane compared with the basal membrane (Fig-
ure 3B). Prior to lumenization, mCherryCAAX-rich membranesFigure 2. Formin Activity Promotes F-Actin Polymerization at EC Junc
(A) Coexpression of fmnl3-EGFP and DCX-mCherry in ISV at 32 hpf. Scale bar re
(B and C) ISVs of Tg(fli1ep:DCX-EGFP);Tg(kdr-l:ras-Cherry)s916 embryos injected
(D–F) Tg(fli1ep:DCX-EGFP);Tg(kdr-l:ras-Cherry)s916 embryos were treated with DM
51–52 hpf. Arrowheads show microtubule filaments. Black arrows show apical
represent 20 mm.
(G) Mosaic endothelial fmnl3-mCherry expression in Tg(fli1ep:Lifeact-EGFP) em
junctions. Scale bar represents 20 mm.
(H–J) 3 to 4 dpf Tg(fli1ep:Lifeact-EGFP) embryos were treated with DMSO or 10
aorta. PCV, posterior cardinal vein. SIA, subintestinal artery. Scale bars represent
(K–M) Fluorescence recovery of EGFP-Actin at cell junctions after photobleaching
10 mM SMIFH for 3 or 5 hr prior to photobleaching. Scale bar represents 10 mm. P
treatments. Data represent mean ± SD.
See also Figure S2.
Developmaccumulate along F-actin-positive cell junctions (35.5 hpf; Fig-
ures 3A and 3B) followed by their expansion along the junctions
to form a lumen (Figure 3B). Cell rearrangements subsequently
establish longitudinal junctions along ISVs (Figure 3B; Movie
S1) (Herwig et al., 2011). However, in 5 of 10 ISVs of fmnl3 mor-
phants, we were unable to observe this multistep process lead-
ing to lumen formation. Although we were able to detect F-actin
in filopodia and at the cell cortex, we could not observe distinct
F-actin cables at cell junctions upon knockdown of fmnl3 from
35.8 to 43 hpf (Figures 3C and 3D; Movie S2). Concomitantly,
ISVs that did not establish distinct junctional F-actin cables failed
to form lumen (five of five ISVs), suggesting that the formation of
F-actin cables at EC junctions is functionally linked with lumen
formation. Although mCherryCAAX-rich membranes accumu-
lated in fmnl3 morphants (magenta arrows, Figure 3D), they
formed vacuoles of variable sizes instead of a seamless lumen
(Figure 3D). Furthermore, staining for podocalyxin-like 2
(Pdxl2), an apical membrane marker (Herwig et al., 2011), at 32
and 49 hpf showed that ECs of fmnl3 morphants can form apical
domains (Figures S3A–S3D). These findings suggest that fmnl3
does not regulate endothelial apical polarity establishment that
is required for lumen formation.
Occasionally, junctional F-actin assembly and lumenization
occurred but were not maintained in fmnl3 morphants (2 of 10
ISVs). Figure 3E shows an example in which apical membranes
expanded to form a continuous lumen within the ISV-DLAV
network. However, the reactivation of an EC, as demonstrated
by filopodia formation (from 40.7 hpf, Figure 3E; Movie S3), led
the cell to slide over the neighboring cell, breaking cell contact
and lumen continuity. Similarly, time-lapse movies of ISVs
and DLAV with mosaic fmnl3DC expression showed defects in
vessel lumenization or connection (9 of 21 vessels; Figure 3F;
Movie S3).
Together, these observations suggest that, upon decreased
fmnl3 or formin activity, diminished junctional F-actin assembly
compromises junctional integrity, leading to disrupted lumen
network within the vasculature.
Formin Activity Stabilizes Adherens Junctions
When grown to confluency, ECs form linear adherens junctions
that are associated with parallel F-actin cables (Huveneers
et al., 2012; Figures S4A and S4B). A second type of junction,
focal adhesion junction (FAJ), shows perpendicular VE cadherin
(VEC) orientation that is attached to radial actin bundles. FAJs
are highly motile, constantly remodel, and commonly appear attions
presents 10 mm.
with control or fmnl3 morpholino at 49 hpf.
SO, 10 mM SMIFH2, or 0.5 mg/ml nocodazole at 48 hpf for 2 hr and imaged at
membrane, and red arrows show microtubule organizing center. Scale bars
bryo from 33 hpf. Arrowheads show localization of fmnl3 with F-actin at cell
mM SMIFH2 for 4–5 hr. Arrowheads show serrated F-actin cables. DA, dorsal
20mm. (J) Image analysis of F-actin cable profile at junctions of the DA or PCV.
. Three dpf Tg(fli1ep:EGFP-Actin) embryos were treated with DMSO for 5 hr or
lots of EGFP-Actin mobile fraction (L) and half-life (M) are shown from different
ental Cell 32, 123–132, January 12, 2015 ª2015 Elsevier Inc. 127
Figure 3. Junctional F-Actin Cables Assemble and Rearrange during Lumen Formation
(A–D) Stills from time-lapse movies illustrating ISV lumenization in uninjected and in fmnl3 morpholino-injected Tg(fli1ep:Lifeact-EGFP);Tg(kdr-l:ras-Cherry)s916
embryos. The magenta arrow shows apical membrane. The black arrow show basal membrane, and the arrowhead shows junctional F-actin cable. The asterisk
shows lumen in (B) and vacuole in (D). Scale bars represent 10 mm.
(E and F) Stills from a time-lapse movie of the DLAV from a Tg(fli1ep:Lifeact-EGFP);Tg(kdr-l:ras-Cherry)s916 embryo injected with fmnl3 morpholino (E) or
Tg(fli1ep:Lifeact-EGFP) embryo with mosaic fmnl3DC expression (*) (F). The arrow shows activated EC, and the arrowhead shows vessel disconnection. Scale
bar represents 10 mm.
See also Figure S3 and Movies S1, S2, and S3.the rear of cells (Huveneers et al., 2012). Live imaging of ECs ex-
pressing VEC-EGFP revealed that within minutes of SMIFH2
treatment linear junctions disassembled into clusters and FAJs
were displaced (14 of 16 movies; Figure 4B; Movie S4). Conse-
quently, cells recoiled from each other revealing high tension in128 Developmental Cell 32, 123–132, January 12, 2015 ª2015 ElseviFAJs. In addition, ECs under shear stress displayed a change
in junctional morphology after SMIFH2 treatment. Intercellular
gaps formed at the long axis of the cells, as evidenced by two
zona occludens 1 (ZO1)-positive membranes between ECs (Fig-
ure S4C). Furthermore, some of the remaining junctions were noter Inc.
associated with F-actin cables (Figure S4D). These findings
strongly implicate formins in stabilizing EC junctions.
In vivo, ISVs of 2 dpf embryos display VEC- and ZO1-positive
junctions that are lined with F-actin cables and arranged in a
multicellular organization with longitudinal and ring-shaped junc-
tions (Figures 4C and 4E) (Herwig et al., 2011; Phng et al., 2013).
Longitudinal junctions arise through cell rearrangements from
ring-shaped junctions, which first form at sites of new EC con-
tacts, during vessel development. They are therefore hallmarks
of cell rearrangement and indicators of junction evolution. We
next examined whether VEC binding to the actin cytoskeleton
is required for junction stability and/or organization. To address
this, we analyzed VEC mutant embryos (VECubs8) expressing a
truncated form of VEC in which the C terminus, which harbors
the actin binding domain, is replaced by EGFP (VECDC-EGFP).
At 52 hpf, ISVs of WT and Tg(UAS:VECDC-EGFP)ubs12 embryos
displayed a complex organization of junctions with 69.6%± 14%
and 67%±12.8%, respectively, of the ISV displaying two parallel
junctions extending along the vessel (Figures S4E and S4G). In
VECubs8;Tg(UAS:VECDC-EGFP)ubs12 embryos, there was a
decrease in the number of vessels segments with two junctions
(52.3% ± 23.7%; Figures S4F and S4G) and an increase in vari-
ability in the number of parallel junctions (Figure S4G), suggest-
ing a decrease in junctional stability when VEC is not linked to the
actin cytoskeleton.
A more prominent effect on junction organization was
observed when formin function was inhibited. Knockdown of
fmnl3 resulted in discontinuous junctions with only ring-shaped
junctions remaining within ISVs and the DLAV (Figure 4D). Occa-
sionally, we observed remnants of a VEC- and ZO1-positive
junction devoid of Lifeact (Figure 4D), suggesting that loss of
junctional F-actin precedes junction destabilization. Similar
discontinuous junction arrangements were also detected after
SMIFH2 treatment in 2 dpf embryos (Figure 4F), and increasing
the duration of formin inhibition increased the number of junc-
tional gaps within ISVs (Figure 4G). Occasionally, we observed
the detachment of cells from each other and disruption to vessel
continuity (Figures 1O, 3E, and 3F), suggesting that prolonged
decrease in junctional F-actin content can further lead to the
disassembly of remaining ring-shaped junctions.
In summary, our results demonstrate a role of formin activity in
promoting junctional F-actin assembly that is required for endo-
thelial junction formation and for maintaining junctions in a multi-
cellular configuration.
DISCUSSION
During vessel formation, F-actin cables are assembled and
maintained at EC junctions (Fraccaroli et al., 2012; Phng et al.,
2013). Here, we show that formin activity is selective for F-actin
assembly at EC junctions, which, when depleted, leads to de-
fects in lumen formation and maintenance. FRAP experiments
revealed that F-actin cables at endothelial junctions are highly
dynamic, show a high turnover rate, and are replenished by
continuous actin polymerization to maintain a stable junctional
F-actin content. While the half-life of junctional EGFP-Actin is
similar in the DA and the PCV (7 s), the mobile fraction of
EGFP-Actin is 10% larger at the junctions of the PCV compared
with the DA, suggesting that there is a higher turnover of, andDevelopmtherefore less stable, junctional F-actin at the PCV. This may
explain why junctions in the PCV are more sensitive to SMIFH2
treatment since EGFP-Actin half-life significantly increased in
the PCV but not in the DA after formin inhibition. The observation
of a complete recovery of the mobile EGFP-Actin fraction under
formin inhibition suggests that other actin nucleating factors
such as Arp2/3 and Spire contribute to actin assembly in EC
junctions and junction stability. Indeed, Arp2/3 was shown to
promote junctional actin nucleation at epithelial cell junctions
(Kovacs et al., 2011; Tang and Brieher, 2012), and intercellular
gaps appear between ECs after Arp2/3 inhibition (Abu Taha
et al., 2014). However, other actin nucleators cannot fully
compensate for reduced formin activity at EC junctions since
we still observe defects in F-actin cable assembly and junction
integrity after fmnl3 knockdown or SMIFH2 treatment.
Cadherin complexes exist dynamically to enable changes in
cell adhesion, rearrangement, and junction permeability. The for-
mation of cadherin junctions depends on extracellular intercad-
herin interaction and intracellular cadherin interaction with
F-actin (Hong et al., 2013). Cadherins form clusters to strengthen
adhesion, a process that requires both dynamic F-actin and
myosin II-mediated contraction of F-actin (Ratheesh and Yap,
2012). Although cadherins can interact through cis- and trans-
binding via their ectodomains, these clusters are unstable; it is
the ability of cadherin binding to F-actin that stabilizes adherens
junctions (Hong et al., 2013; Kametani and Takeichi, 2007; Noda
et al., 2010). Thus, cadherin dynamics and adhesion are coupled
to F-actin dynamics, and it is likely that the cadherin-actin inter-
action evolves during vessel morphogenesis.
During lumen formation of angiogenic vessels, ECs rearrange
to form a multicellular tube in a process that is tightly associated
with junction coalescence and reorganization (Lenard et al.,
2013). In contrast, vasculogenic lumen formation commences
in a multicellular configuration and involves junctional displace-
ment from the apical to the lateral membrane and apical deadhe-
sion of opposing membranes (Strilic et al., 2009). Intriguingly,
although formin inhibition altered junctional F-actin both in ISV
and in DA and PCV, angiogenic lumen formation and mainte-
nance in the ISV were fully dependent on formin function. We
propose that formin activity maintains a pool of F-actin at endo-
thelial junction that reinforces junction stability by regulating the
strength and organization of junctions. This process is critical for
endothelial junctions during cellular rearrangements that drive
lumen formation and stabilization in angiogenesis.
EXPERIMENTAL PROCEDURES
Fish Maintenance and Stocks
Zebrafish (Danio rerio) were raised and staged as previously described
(Kimmel et al., 1995). The following transgenic lines were used: Tg(fli:GFP)y1
(Lawson and Weinstein, 2002), Tg(kdr-l:ras-Cherry)s916 (Hogan et al., 2009),
and Tg(fli1ep:Lifeact-EGFP) (Phng et al., 2013).
Cloning and Constructs
All constructs were generated using the Tol2Kit (Kwan et al., 2007) and the
Multisite Gateway system (Invitrogen). The fli1ep promoter (from Nathan Law-
son) was used to drive endothelial expression of EGFP-human Actin (Clon-
tech), zebrafish fmnl3 (from Shigetomo Fukuhara and Naoki Mochizuki), and
EGFP-DCX (Distel et al., 2010). Fmnl3 was placed under the CMV/SP6 pro-
moter (Kwan et al., 2007) for the generation of fmnl3 cappedmRNA. For induc-
ible expression of fmnl3DC, LexPR transactivator was placed under the fli1epental Cell 32, 123–132, January 12, 2015 ª2015 Elsevier Inc. 129
(legend on next page)
130 Developmental Cell 32, 123–132, January 12, 2015 ª2015 Elsevier Inc.
promoter, and a second plasmid encoding fmnlDCwas placed under the LexA
operator (Emelyanov and Parinov, 2008). Embryos were injected with 25
plasmid and 25 ng/ml transposase RNA. Capped mRNAs were transcribed
with the SP6 mMessage mMachine Kit (Ambion). Embryos injected with
pDestTol2-fli1ep:EGFP-Actin and pDestTol2-fli1ep:EGFP-DCX plasmids
were raised to adults and screened for founders.
Morpholino Injections, Chemical Treatments, and
Microangiography
Ten ng standard control or fmnl3 translation blocking (Hetheridge et al., 2012)
antisensemorpholino (GeneTools) was injected into the yolk of one- to two-cell
stage embryos. SMIFH2 (Merck Millipore) was dissolved in DMSO to 50 mM,
stored at20C, and diluted in Danieau’s Buffer containing 0.4%DMSO (con-
trol). To induce gene expression using the LexPR system, embryos were
treatedwith 20 mMmifepristone (Sigma) for 3–4 hr and thenwashed. To assess
vessel perfusion, 2 nl Qdot 705 Quantum Dots (Life Technologies) were in-
jected into the sinus venosus at 2 dpf.
Live Imaging
Live embryos were mounted in 0.8% low melting agarose containing 0.01%
Tricaine (Sigma) and bathed in Danieau’s buffer. Cells were incubated at
37C with 5% CO2. Images and time-lapse movies were acquired using an
Andor Revolution 500 spinning disk confocal built on a Nikon TiE inverted
microscope; z stacks were flattened by maximum projection unless otherwise
stated. Image processing, measurements, and stitching (Preibisch et al., 2009)
were performed using ImageJ 1.47j software. XY drifts were corrected by
using the StackReg Translation plugin (The´venaz et al., 1998).
Statistical Analysis
Statistical analyses were performed using chi-squared test or Student’s two-
tailed t test in Prism 5.0 (GraphPad). A p value% 0.05 was considered statis-
tically significant.
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